Idarubicin Clinical Trials

• Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002989 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00107523 - Active, not recruiting
  adult acute myeloid leukemia
  
• Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00096122 - Active, not recruiting
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; ...
  
• VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00505700 - Active, not recruiting
  Leukemia
  
• Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00193973 - Active, not recruiting
  Primary Central Nervous System Lymphoma
  
• Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00077116 - Active, not recruiting
  adult acute myeloid leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes
  
• Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML
  ClinicalTrials.gov Identifier: NCT00382954 - Recruiting
  Acute Myelogenous Leukemia
  
• Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00210366 - Recruiting
  Lymphoma, B-Cell
  
• Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00528398 - Recruiting
  Leukemia
  
• Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00528450 - Recruiting
  Leukemia
  
• Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00469859 - Recruiting
  Leukemia
  
• Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00093483 - Recruiting
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
  
• Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result
  ClinicalTrials.gov Identifier: NCT00146120 - Active, not recruiting
  Acute Myeloid Leukemia
  
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002532 - Active, not recruiting
  recurrent adult acute lymphoblastic leukemia
  
• Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)
  ClinicalTrials.gov Identifier: NCT00542971 - Recruiting
  AML; High-Risk MDS; Acute Myeloid Leukemia; High-Risk Myelodysplastic Disorder
  
• Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients with Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00086099 - Active, not recruiting
  Leukemia; Acute Myeloid Leukemia
  
• Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00002816 - Active, not recruiting
  Quality of Life; recurrent childhood acute lymphoblastic leukemia
  
• Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002868 - Active, not recruiting
  chronic phase chronic myelogenous leukemia
  
• Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML
  ClinicalTrials.gov Identifier: NCT00074737 - Completed
  Acute Myelogenous Leukemia
  
• Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA)
  ClinicalTrials.gov Identifier: NCT00465933 - Recruiting
  Acute Promyelocytic Leukemia
  
• Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00331513 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Combination Chemotherapy in Treating Patients With Lymphoma
  ClinicalTrials.gov Identifier: NCT00002835 - Active, not recruiting
  Lymphoma
  
• Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients with Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00124813 - Recruiting
  Multiple Myeloma
  
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002517 - Active, not recruiting
  Myeloid Leukemia; Myelodysplastic Syndromes; Refractory Anemia
  
• Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003783 - Active, not recruiting
  L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; ...
  
• Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002833 - Active, not recruiting
  Chronic Myelogenous Leukemia; Graft vs Host Disease; Philadelphia chromosome; Myeloid Leukemia; Refractory Anemia; Chronic Myelomonocytic Leukemia
  
• Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003729 - Active, not recruiting
  L2 childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; recurrent childhood acute lymphoblastic leukemia
  
• Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)
  ClinicalTrials.gov Identifier: NCT00422591 - Recruiting
  Leukemia; Acute Myeloid Leukemia; AML
  
• Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00006367 - Active, not recruiting
  idiopathic myelofibrosis; Polycythemia Vera; Essential Thrombocythemia; Agnogenic Myeloid Metaplasia
  
• Cladribine, Cytarabine and Idarubicin in Patients with Relapsed Acute Myelocytic Leukemia (AML)
  ClinicalTrials.gov Identifier: NCT00126321 - Recruiting
  Leukemia, Myelocytic, Acute
  
• Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00005823 - Active, not recruiting
  Acute Myeloid Leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; ...
  
• Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00002658 - Active, not recruiting
  Myeloid Leukemia; Neutropenia
  
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002926 - Active, not recruiting
  Myelodysplastic Syndromes; Myeloid Leukemia; Refractory Anemia; Refractory Cytopenia
  
• Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00052299 - Active, not recruiting
  adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
  
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002701 - Active, not recruiting
  untreated adult acute myeloid leukemia; adult acute promyelocytic leukemia (M3)
  
• Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00003603 - Active, not recruiting
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002549 - Active, not recruiting
  adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
  
• Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00003602 - Active, not recruiting
  untreated adult acute myeloid leukemia; refractory anemia with excess blasts; refractory anemia with excess blasts in transformation; ...
  
• Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00006122 - Active, not recruiting
  untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
  
• Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00002719 - Active, not recruiting
  adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
  
• Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00004878 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; Graft Versus Host Disease; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission
  ClinicalTrials.gov Identifier: NCT00002609 - Active, not recruiting
  childhood acute myeloid leukemia in remission; childhood acute promyelocytic leukemia (M3); adult acute myeloid leukemia in remission; ...
  
• Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002800 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; untreated adult acute myeloid leukemia; de novo myelodysplastic syndrome; ...
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002761 - Active, not recruiting
  relapsing chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
  
• Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00016159 - Active, not recruiting
  adult acute myeloid leukemia in remission; childhood acute myeloid leukemia in remission; adult acute promyelocytic leukemia (M3); ...
  
• Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003758 - Active, not recruiting
  acute leukemia; childhood cancer; hematopoietic/lymphoid cancer; Cancer; Leukemia; cellular diagnosis, childhood acute myeloid leukemia; ...
  
• Clofarabine Combinations in Relapsed/Refractory AML, MDS and Myeloid Blast Phase CML
  ClinicalTrials.gov Identifier: NCT00067028 - Recruiting
  Acute Myeloid Leukemia; Myelodysplastic Syndrome; Chronic Myeloid Leukemia
  
• Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002771 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00002945 - Active, not recruiting
  adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute monocytic leukemia (M5); ...
  
• Chemotherapy, Biological Therapy, and/or Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00025402 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• Randomized Phase Iii-Study On Valproic Acid In Combination With All-Trans Retinoic Acid, Standard Induction- And Consolidation Therapy In Older Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00151255 - Recruiting
  Acute myeloid leukemia, age > 60 years
  
• Randomized Phase Ii-Study On Valproic Acid, All-Trans Retinoic Acid And Their Combination In Induction And Consolidation Therapy As Well As Pegfilgrastim After Consolidation Therapy In Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00151242 - Recruiting
  Acute Myeloid Leukemia
  
• Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003405 - Active, not recruiting
  untreated adult acute myeloid leukemia; childhood acute megakaryocytic leukemia (M7); adult acute differentiated monocytic leukemia (M5b); ...
  
• Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00023920 - Completed
  blastic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
  
• Combination Chemotherapy With or Without Interferon alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003639 - Active, not recruiting
  stage III grade II follicular mixed cell lymphoma; stage IV grade II follicular mixed cell lymphoma; ...
  
• Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00096148 - Completed
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; ...
  
• Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002565 - Completed
  Lymphoma
  
• Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00003178 - Completed
  Acute Myeloid Leukemia
  
• Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00003268 - Completed
  adult acute myeloid leukemia; Drug Toxicity
  
• Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00006232 - Completed
  stage II multiple myeloma; stage III multiple myeloma
  
• Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002812 - Completed
  L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia
  
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002798 - Completed
  Myeloid Leukemia; Refractory Anemia
  
• Phase II Study of Intensive Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantion in Patients With Chronic Myelogenous Leukemia or High Risk Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00004905 - Completed
  adult acute myeloid leukemia in remission; chronic phase chronic myelogenous leukemia; recurrent adult acute myeloid leukemia; ...